Fibrocell Science, Inc.
405 Eagleview Boulevard
Exton, Pennsylvania 19341
August 7, 2018
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Fibrocell Science, Inc.
Registration Statement on Form S-1(File No. 333-226397)
Filed July 27, 2018
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Fibrocell Science, Inc. hereby requests the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-1 to become effective on August 8, 2018, at 4:00PM Eastern Time, or as soon thereafter as is practicable.
Please feel free to direct any questions or comments concerning this request to Steve Abrams of Hogan Lovells US LLP at (267) 675-4671.
FIBROCELL SCIENCE, INC.
By: /s/ John M. Maslowski
Name: John M. Maslowski
| |
| Title: | President and Chief Executive Officer |
